C-RAD AB: Cooperation in motion management
C-RAD announces collaboration on the development motion management solutions for radiation therapy C-RAD with its four fully owned subsidiaries are all active are all active in the field of therapy. C-RAD will in cooperation with Swedish Cancer Institute in Seattle, Washington participate in the development of motion management solutions based on the new C-RAD Catalyst system. For tumors impacted by respiratory motion, normal tissue toxicities limit the ability of radiation oncologists to deliver curative doses of radiation. By employing advanced motion management techniques,